What question did this study set out to answer?

This review examines the applications and outcomes of dermal regenerative matrices in reconstructive surgeries.

July 19, 2026Indian Journal of Plastic Surgery0 citationsOpen Access

The Promises and Pitfalls of Dermal Regenerative Matrices in Reconstructive Surgery: A Narrative Review

MMMohd. Altaf Mir SKSeerat Kular RKRahul Kaushik

Key Points

This review examines the applications and outcomes of dermal regenerative matrices in reconstructive surgeries.
Conducted a PubMed search from 2015 to 2025, identifying 230 articles, with 189 included for characterization of DRM use.
Analyzed 23 comparative studies focused on acellular dermal matrices in immediate implant-based breast reconstruction.
Evaluated histopathological analyses comparing biological and synthetic matrices.
DRMs show similar complication rates and patient satisfaction between human-derived and bovine-derived ADMs in immediate breast reconstruction.
One-stage ADM-assisted reconstruction has longer operative times and potentially increased early complications compared to two-stage approaches.
Biological matrices promote better tissue integration and neovascularization than synthetic meshes, which provoke a more significant foreign-body response.

Abstract

Abstract Dermal regenerative matrices (DRMs) are extracellular matrix–based biomaterials designed to provide structural support and promote site-appropriate tissue regeneration; acellular dermal matrices (ADMs) represent the most widely used clinical subtype of DRMs. Originally developed for burn management, their indications have expanded to include implant-based breast reconstruction (IBBR), chronic wounds, and complex soft-tissue defects across multiple anatomical regions. However, heterogeneity in biological source, processing, and structural design has resulted in variable outcomes and uncertainty regarding optimal selection. This narrative review synthesizes contemporary clinical evidence on DRMs across reconstructive domains, with a focused comparative analysis of ADMs in immediate IBBR. A PubMed search from 2015 to 2025 identified 230 articles, of which 189 were included to characterize the overall spectrum of DRM use, and 23 comparative studies were assessed in detail. DRMs demonstrated broad applicability, most commonly in breast reconstruction and skin and soft-tissue repair. Comparative evidence in immediate IBBR indicates largely similar overall complication rates, implant loss, and patient-reported satisfaction between human-derived and bovine-derived ADMs, although one-stage ADM-assisted reconstruction is associated with longer operative times, higher costs, and, in some studies, increased early complications compared with two-stage approaches. Histopathological analyses suggest differential tissue integration, with biological matrices promoting neovascularization and myofibroblast activity, while synthetic meshes elicit a more pronounced foreign-body response. Outside the IBBR domain, comparative data remain limited. Overall, the benefits of DRMs over conventional methods are context-specific and not uniformly demonstrated. Robust multicenter studies evaluating long-term outcomes and cost-effectiveness are required to refine indications and guide evidence-based clinical practice.

Ask AI

Helpful

Bookmark

View Full Paper